ATE190505T1 - Verwendung von ibuprofen-beta-cyclodextrin- komplex für die orale verabreichung - Google Patents
Verwendung von ibuprofen-beta-cyclodextrin- komplex für die orale verabreichungInfo
- Publication number
- ATE190505T1 ATE190505T1 AT93907987T AT93907987T ATE190505T1 AT E190505 T1 ATE190505 T1 AT E190505T1 AT 93907987 T AT93907987 T AT 93907987T AT 93907987 T AT93907987 T AT 93907987T AT E190505 T1 ATE190505 T1 AT E190505T1
- Authority
- AT
- Austria
- Prior art keywords
- ibuprofen
- beta
- pct
- cyclodextrin complex
- oral administration
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
- A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nanotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Crystallography & Structural Chemistry (AREA)
- Molecular Biology (AREA)
- Medical Informatics (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB929207990A GB9207990D0 (en) | 1992-04-10 | 1992-04-10 | Pharmaceutical composition |
PCT/GB1993/000702 WO1993020850A1 (en) | 1992-04-10 | 1993-04-02 | Pharmaceutical composition |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE190505T1 true ATE190505T1 (de) | 2000-04-15 |
Family
ID=10713877
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT93907987T ATE190505T1 (de) | 1992-04-10 | 1993-04-02 | Verwendung von ibuprofen-beta-cyclodextrin- komplex für die orale verabreichung |
Country Status (13)
Country | Link |
---|---|
US (1) | US5597583A (de) |
EP (1) | EP0633787B1 (de) |
JP (1) | JPH07505645A (de) |
KR (1) | KR950700762A (de) |
AT (1) | ATE190505T1 (de) |
AU (1) | AU667095B2 (de) |
CA (1) | CA2117762A1 (de) |
DE (1) | DE69328087T2 (de) |
ES (1) | ES2145772T3 (de) |
GB (1) | GB9207990D0 (de) |
HK (1) | HK1012260A1 (de) |
NZ (1) | NZ251393A (de) |
WO (1) | WO1993020850A1 (de) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2531295A (en) * | 1994-05-27 | 1995-12-21 | Farmarc Nederland Bv | Pharmaceutical composition |
GB9625589D0 (en) * | 1996-12-10 | 1997-01-29 | Boots Co Plc | Therapeutic agents |
IT1301966B1 (it) | 1998-07-30 | 2000-07-20 | Zambon Spa | Composizioni farmaceutiche ad attivita' analgesica |
US6211246B1 (en) * | 1999-06-10 | 2001-04-03 | Mcneil-Ppc, Inc. | Rapidly absorbed liquid compositions |
ES2171110B1 (es) * | 2000-03-03 | 2003-06-16 | Aplicaciones Farmacodinamicas | Composicion farmaceutica a base de ibuprofeno y procedimiento para su preparacion. |
CA2417661A1 (en) * | 2000-08-02 | 2002-02-07 | Malope Company Limited | Diagnosis and treatment of non-ulcer dyspepsia based on hypothalamic-pituitary-adrenal axis abnormality |
PT1411899E (pt) * | 2001-08-01 | 2009-04-24 | Novartis Ag | Composição de mascaramento de sabor |
KR100567131B1 (ko) * | 2004-01-05 | 2006-04-05 | 신일제약주식회사 | 쓴맛을 차폐한 아르기닌 함유 이부프로펜 경구투여 액상조성물 |
EP1942877A4 (de) * | 2005-11-02 | 2011-09-14 | Teikoku Pharma Usa Inc | Organoleptisch annehmbare orale dosierformen von ibuprofen, herstellungsverfahren und anwendung |
US20070207206A1 (en) * | 2006-03-02 | 2007-09-06 | Rice Bronwyn C | Chewable pain formula |
WO2007109057A2 (en) * | 2006-03-16 | 2007-09-27 | Novartis Ag | Solid dosage form containing a taste masked active agent |
EP2253329B1 (de) * | 2009-04-27 | 2016-09-21 | Laboratorio de Aplicaciones Farmacodinamicas, S.A. | Orale Ibuprofenlysinat-Suspension |
CN102448499A (zh) * | 2009-04-27 | 2012-05-09 | 药效学应用实验室股份有限公司 | 赖氨酸布洛芬口服混悬剂 |
CN114588107B (zh) * | 2022-04-06 | 2023-04-18 | 河北一品生物医药有限公司 | 一种布洛芬赖氨酸盐注射液及其制备方法 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
YU43290B (en) * | 1986-11-13 | 1989-06-30 | Lek Tovarna Farmacevtskih | Process for preparing inclusioned complex of ibuproxane with beta-cyclodextrine |
CA1298290C (en) * | 1987-01-09 | 1992-03-31 | Herand M. Markarian | Solution ibuprofen complexes, compositions and processes for preparing the same |
GB8813682D0 (en) * | 1988-06-09 | 1988-07-13 | Reckitt & Colmann Prod Ltd | Pharmaceutical compositions |
US5024997A (en) * | 1990-06-22 | 1991-06-18 | American Home Products Corporation | Palatable ibuprofen solutions |
DE4038314A1 (de) * | 1990-11-30 | 1992-06-04 | Puetter Medice Chem Pharm | Komplexe des aktiven enantiomers des ibuprofens mit cyclodextrin |
-
1992
- 1992-04-10 GB GB929207990A patent/GB9207990D0/en active Pending
-
1993
- 1993-04-02 CA CA002117762A patent/CA2117762A1/en not_active Abandoned
- 1993-04-02 EP EP93907987A patent/EP0633787B1/de not_active Expired - Lifetime
- 1993-04-02 ES ES93907987T patent/ES2145772T3/es not_active Expired - Lifetime
- 1993-04-02 NZ NZ251393A patent/NZ251393A/en unknown
- 1993-04-02 JP JP5518085A patent/JPH07505645A/ja active Pending
- 1993-04-02 WO PCT/GB1993/000702 patent/WO1993020850A1/en active IP Right Grant
- 1993-04-02 US US08/318,739 patent/US5597583A/en not_active Expired - Fee Related
- 1993-04-02 AU AU38987/93A patent/AU667095B2/en not_active Ceased
- 1993-04-02 AT AT93907987T patent/ATE190505T1/de not_active IP Right Cessation
- 1993-04-02 DE DE69328087T patent/DE69328087T2/de not_active Expired - Lifetime
-
1994
- 1994-10-10 KR KR1019940703598A patent/KR950700762A/ko not_active Application Discontinuation
-
1998
- 1998-12-15 HK HK98113526A patent/HK1012260A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
US5597583A (en) | 1997-01-28 |
AU667095B2 (en) | 1996-03-07 |
DE69328087D1 (de) | 2000-04-20 |
JPH07505645A (ja) | 1995-06-22 |
HK1012260A1 (en) | 1999-07-30 |
CA2117762A1 (en) | 1993-10-28 |
NZ251393A (en) | 1996-08-27 |
AU3898793A (en) | 1993-11-18 |
KR950700762A (ko) | 1995-02-20 |
DE69328087T2 (de) | 2000-08-24 |
GB9207990D0 (en) | 1992-05-27 |
ES2145772T3 (es) | 2000-07-16 |
WO1993020850A1 (en) | 1993-10-28 |
EP0633787B1 (de) | 2000-03-15 |
EP0633787A1 (de) | 1995-01-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69328087D1 (de) | Verwendung von ibuprofen-beta-cyclodextrin-komplex für die orale verabreichung | |
DE69115280D1 (de) | Indolderivate, die die leukotrienbiosynthese hemmen. | |
DE69111077D1 (de) | Chinazolinderivate um die antitumorwirkung zu verbessern. | |
ES2113652T3 (es) | Pamoato de risperidona. | |
TR199700844T1 (xx) | Pirazolil-Benzoil T�revleri. | |
AR038430A2 (es) | Derivados de parahercuamida b | |
FI942313A (fi) | Välituote atsitromysiiniä varten | |
IL118167A0 (en) | Pyrazolo (1,5a) pyrimidines their preparation and use | |
FI910653A0 (fi) | Synteettiset reseptorianalogit | |
DE69224295D1 (de) | Pestizid und fungizid | |
MX9401406A (es) | Agentes receptores de adenosina selectivos para intensificar el conocimiento. | |
FI102185B1 (fi) | Anionisten diatsoväriaineiden konsentroidut, vesipitoiset liuokset | |
NO941084L (no) | Neuroleptiske 2-substituerte perhydro-1-H-pyrido[1,2-aÅpyraziner | |
TR26431A (tr) | ANIYONIK AZO BOYAR MADDELERININ KONSANTRE, SULU CÖZELTILERININ üRETILMESINE MAHSUS USUL. | |
FR2734724B1 (fr) | Application de derives de pyrrolidine a la preparation de medicaments destines au traitement de l'alcoolisme | |
FI934977A0 (fi) | Foerfarande foer att reducera elkfoerbrukningen i mikroprocessorbaserade,isynnerhet foer publika telefonstationer avsedda anordningar | |
ES2128426T3 (es) | Retinoides acuosolubles. | |
MX9201288A (es) | Metodo de tratamiento. | |
ES2098119T3 (es) | Nuevas triazoloquinazolinas, su obtencion y empleo. | |
NO974687D0 (no) | Kondenserte <beta>-carboliner | |
DE69407180D1 (de) | Fluoro-nukleosid-reinigung | |
IT8820800A0 (it) | Macchina rimagliatrice rettilinea, in particolare per l'applicazione di bordini ad un capo di abbigliamento. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |